TY - JOUR
T1 - MESENTERIC VASCULAR ANGIOTENSIN‐CONVERTING ENZYME IS INCREASED IN EXPERIMENTAL DIABETES MELLITUS
AU - Jandeleit, Karin
AU - Rumble, Jon
AU - Jackson, Bruce
AU - Cooper, Mark E.
PY - 1992/5
Y1 - 1992/5
N2 - 1. Diabetes mellitus was induced by streptozotocin in male Wistar rats, and angiotensin‐converting enzyme measured in plasma and mesenteric vessels 3 weeks later. 2. Diabetes was associated with increased mesenteric wet weight/ bodyweight ratio (control 0.2 s.e.m. 0.02 mg/g, n= 21, vs diabetes 1.0 s.e.m. 0.3 mg/g, n= 27, P < 0.01, ANOVA). 3. Plasma angiotensin‐converting enzyme activity was increased in diabetic rats (98 s.e.m. 3 nmol HL/mL per min) compared with controls (64 s.e.m. 6 nmol HL/mL per min, P < 0.01, ANOVA). 4. Mesenteric vessel angiotensin‐converting enzyme was increased in diabetes mellitus estimated by radioligand binding site density (fmol/mg protein; 1407 s.e.m. 166 fmol/mg protein) compared with controls (890 s.e.m. 56 fmol/mg protein, P < 0.05, ANOVA) and by enzyme kinetic assay (diabetes, 15.5 s.e.m. 1.5 nmol HL/mg protein per min, controls, 8.3 s.e.m. 0.7 nmol HL/mg protein per min, P < 0.01, ANOVA). The equilibrium dissociation constant of ligand‐angiotensin‐converting enzyme interaction was unchanged. 5. Increased vascular angiotensin‐converting enzyme concentration may contribute to vascular hypertrophy and diabetic vasculopathy by increased local synthesis of angiotensin II.
AB - 1. Diabetes mellitus was induced by streptozotocin in male Wistar rats, and angiotensin‐converting enzyme measured in plasma and mesenteric vessels 3 weeks later. 2. Diabetes was associated with increased mesenteric wet weight/ bodyweight ratio (control 0.2 s.e.m. 0.02 mg/g, n= 21, vs diabetes 1.0 s.e.m. 0.3 mg/g, n= 27, P < 0.01, ANOVA). 3. Plasma angiotensin‐converting enzyme activity was increased in diabetic rats (98 s.e.m. 3 nmol HL/mL per min) compared with controls (64 s.e.m. 6 nmol HL/mL per min, P < 0.01, ANOVA). 4. Mesenteric vessel angiotensin‐converting enzyme was increased in diabetes mellitus estimated by radioligand binding site density (fmol/mg protein; 1407 s.e.m. 166 fmol/mg protein) compared with controls (890 s.e.m. 56 fmol/mg protein, P < 0.05, ANOVA) and by enzyme kinetic assay (diabetes, 15.5 s.e.m. 1.5 nmol HL/mg protein per min, controls, 8.3 s.e.m. 0.7 nmol HL/mg protein per min, P < 0.01, ANOVA). The equilibrium dissociation constant of ligand‐angiotensin‐converting enzyme interaction was unchanged. 5. Increased vascular angiotensin‐converting enzyme concentration may contribute to vascular hypertrophy and diabetic vasculopathy by increased local synthesis of angiotensin II.
KW - blood vessels
KW - diabetes mellitus
KW - renin‐angiotensin system.
UR - http://www.scopus.com/inward/record.url?scp=0026511425&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1681.1992.tb00468.x
DO - 10.1111/j.1440-1681.1992.tb00468.x
M3 - Article
C2 - 1325883
AN - SCOPUS:0026511425
SN - 0305-1870
VL - 19
SP - 343
EP - 347
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 5
ER -